CancerBro explains treatment of localised breast cancer
CancerBro
2018-04-17
Views 3
In this video, CancerBro will explain treatment of localised breast cancer. Watch this video to better understand and share it to spread awareness.
Video Transcript:
If we see the localised disease in detail, it includes cases till T3, that is tumor more than 5 cm but not infiltrating the skin or chest wall, or N1, that is presence of mobile axillary lymph nodes.
In early stage disease, the decision to move ahead with BCS depends on patient as well as oncologist.
The patient has to be willing for it and give consent for the same, and oncologist has to look for any contraindications for the procedure.
If everything is in favor, and the tumor size is small, breast conservation surgery maybe done correctly.
Whereas if the tumor is large, we first have to give neo-adjuvant chemotherapy to shrink the tumor, and then reassess for breast conservation surgery, depending upon the response to chemotherapy.
So, the decision to add chemotherapy in the neoadjuvant or adjuvant setting is taken on an individual patient basis, after discuss in a tumor board.
Also the decision to add hermonal therapy and targeted therapy is taken depending upon the ER, PR and her-2 receptor status and along with other factors.
After Breast Conservation Surgery, radiation therapy is given in all the cases.
Where as after modified radical mastectomy, the decision to add radiation therapy is taken by the radio oncologist depending upon the T-status, N-status, margins of resection along with other factors.
Subscribe to our YouTube channel and join the Mrs. Brooks journey to know all about breast cancer. CancerBro will walk you through risk factors, stagings, and respective treatments of breast cancer.
CancerBro is also active on social media channels. Follow him to get rich and authoritative content related to cancer awareness, risk factors, symptoms, diagnosis, treatment, etc.
Facebook - https://www.facebook.com/officialcancerbro
Instagram - https://www.instagram.com/official_cancerbro
Twitter - https://twitter.com/cancer_bro/
Website - http://www.cancerbro.com/
Video Transcript:
If we see the localised disease in detail, it includes cases till T3, that is tumor more than 5 cm but not infiltrating the skin or chest wall, or N1, that is presence of mobile axillary lymph nodes.
In early stage disease, the decision to move ahead with BCS depends on patient as well as oncologist.
The patient has to be willing for it and give consent for the same, and oncologist has to look for any contraindications for the procedure.
If everything is in favor, and the tumor size is small, breast conservation surgery maybe done correctly.
Whereas if the tumor is large, we first have to give neo-adjuvant chemotherapy to shrink the tumor, and then reassess for breast conservation surgery, depending upon the response to chemotherapy.
So, the decision to add chemotherapy in the neoadjuvant or adjuvant setting is taken on an individual patient basis, after discuss in a tumor board.
Also the decision to add hermonal therapy and targeted therapy is taken depending upon the ER, PR and her-2 receptor status and along with other factors.
After Breast Conservation Surgery, radiation therapy is given in all the cases.
Where as after modified radical mastectomy, the decision to add radiation therapy is taken by the radio oncologist depending upon the T-status, N-status, margins of resection along with other factors.
Subscribe to our YouTube channel and join the Mrs. Brooks journey to know all about breast cancer. CancerBro will walk you through risk factors, stagings, and respective treatments of breast cancer.
CancerBro is also active on social media channels. Follow him to get rich and authoritative content related to cancer awareness, risk factors, symptoms, diagnosis, treatment, etc.
Facebook - https://www.facebook.com/officialcancerbro
Instagram - https://www.instagram.com/official_cancerbro
Twitter - https://twitter.com/cancer_bro/
Website - http://www.cancerbro.com/
Report form
RELATED VIDEOS
